Compagnie Gervais Danone

Other

University College Cork

London Health Sciences Centre Research Inc.

Tamara Smokvina

Gianfranco Grompone

Marie-Christine Degivry

Peggy Garault

Isabelle Chambaud

Johan Van Hylckama Vlieg

Sophie Legrain-Raspaud

Gregor Reid

Jeremy Burton

Biliana Lesic

Michel Neunlist

Anne Druesne

Sandrine Capronnier

Jordan Bisanz

Philippe Langella

Douwe Van Sinderen

Claire Queguiner

Artem Khlebnikov

Rebeca Martin Rosique

Anne-Catherine Villain

Thierry Saint Denis

Marc Monaches

Debbie Watson

Mary O'Connell Motherway

Marc Monachese

Jean-Michael Faurie

Thierry Saint-Dennis

The present invention relates to a composition comprising a givenstrain and a givenstrain wherein the ratio of the givenstrain to the givenstrain (LR&#x3b1;:LP&#x3b1;) is higher or equal to 8:1 and to methods thereof.

Probiotic composition comprisingandand methods thereof

The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.

Food grade bacteria for the removal of toxic compounds

The present invention concerns a method for genetically transforming astrain comprising a step of methylation of a shuttle vector in anor a Gram-positive bacterium strain by two type II DNA methyltransferases from a: a methyltransferase enzyme that methylates the adenine base at position 4 of the nucleotide sequence RTCAGG and a methyltransferase enzyme that methylates the cytosine base at position 4 of the nucleotide sequence GGWCC. The present invention also concerns genetic tools and culture media useful for carrying out said method.

Genetic transformation of bifidobacteria

The invention relates to a novel strain ofssp., which is able, inter alia, to improve the function of the enteric nervous system, and to compositions said novel strain.

[object Object]

The present invention relates to food-grade bacteria strain being capable of removing mercury from an aqueous environment.

The invention relates to a new strain ofwhich is able to decrease intestinal barrier permeability. This strain is useful in particular for alleviating intestinal barrier dysfunctions.

The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.

Probiotic strains for use in improving the enteric nervous system

The invention relates to a novel strain ofsubspecies, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.

The invention relates to novel strains of. More specifically, the invention relates to strains ofhaving a lactose-negative phenotype and to the uses thereof in the agri-food industry. The invention also relates to a method for obtaining such strains of

Growing community of inventors

Orsay, France

Tamara Smokvina